NCT04161417

Precision-Panc Master Protocol: Personalising Treatment for Pancreatic Cancer

Precision-Panc Master Protocol: Personalising Treatment For Pancreatic Cancer

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 2,500 (estimated)
• Sponsor: Judith Dixon-Hughes · Academic / Other
• Sex: All
• Age: 16 Years
• Healthy volunteers: Not accepted

Summary

The Precision-Panc Master Protocol is a "portal" protocol for patients with known or suspected pancreatic cancer to be accrued through multiple centres in the UK, with the option of being subsequently enrolled into PRIMUS (Pancreatic canceR Individualised Multi-arm Umbrella Studies) examining different treatment regimens and/or biomarker development. Eligible patients will undergo tumour biopsy and blood collection prospectively for molecular profiling at a central laboratory and the results may be used to inform enrolment to PRIMUS studies.

Conditions

• Neoplasms Pancreatic

Interventions

Type	Name	Description
OTHER	Patients with suspected or confirmed pancreatic cancer will be be asked to provide biopsy material for molecular profiling	Patients with suspected or confirmed pancreatic cancer will be be asked to provide biopsy material for molecular profiling. This will enable patient enrolment into a currently available PRIMUS study

Timeline

• Start date: 2017-11-28
• Primary completion: 2025-12-31
• Completion: 2025-12-31
• First posted: 2019-11-13
• Last updated: 2024-02-08

Locations

33 sites across 1 country: United Kingdom